CANF
Can-Fite BioPharma
CANF
CANF
7 hedge funds and large institutions have $1.84M invested in Can-Fite BioPharma in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.
Holders
7
Holders Change
-4
Holders Change %
-36.36%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
MIH
1
Meitav Investment House
Bene-Beraq,
Israel
|
$518K |
2 |
2
Morgan Stanley
New York
|
$284K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$2K |